Hyderabad, October 15, 2016: (UNI) Hyderabad-headquartered Dr Reddy’s Laboratories Ltd (RDY) announced today that it has launched Aripiprazole tablets, USP, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the United States market approved by the US Food & Drug Administration (USFDA).
The Abilify brand and generic tablets had US sales of approximately 3.1 billion dollars MAT for the most recent twelve months ending in August 2016 according to IMS Health, the Pharmaceutical said in a statement here.
Dr Reddy’s Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30. –United News of India
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…